Predictions
Carnival plc
Start price
Target price
Perf. (%)
€18.10
-
-0.55%
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
GlaxoSmithKline plc
Start price
Target price
Perf. (%)
€14.65
€17.30
-2.85%
Could be very worthwhile Investment >20% year
High dividend yield expected
Good rating
Small Risks for its business
Unilever plc
Start price
Target price
Perf. (%)
€45.28
€60.00
-2.32%
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High dividend yield expected
positive Cash Flow expected
Rio Tinto plc
Start price
Target price
Perf. (%)
€63.61
€72.00
16.88%
Could be worthwhile Investment >10% per year
Medium risks for its business
Market Leader or Top 3
Sustainability is little important
AstraZeneca plc
Start price
Target price
Perf. (%)
€87.23
€95.00
-8.48%
Small cyclical dependencies
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Carnival plc
Start price
Target price
Perf. (%)
€14.95
-
20.40%
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Higher risks for its business
Significant cyclical dependencies
Royal Dutch Shell A
Start price
Target price
Perf. (%)
€15.50
€18.00
12.51%
Could be worthwhile Investment >10% per year
High dividend yield expected
ROE higher than 10% per year
Revenue decline/stagnation expected
Royal Dutch Shell A
Start price
Target price
Perf. (%)
€14.86
-
17.34%
Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Fair valuation
Revenue decline/stagnation expected
AstraZeneca plc
Start price
Target price
Perf. (%)
€83.36
€90.00
-4.23%
Could be worthwhile Investment >10% per year
Higher risks for its business
Carnival plc
Start price
Target price
Perf. (%)
€12.76
€28.00
41.07%
EBIT growth >5% per year expected
Lower EBIT Margin than peer group
negative Cash Flow expected
Bad rating
Royal Dutch Shell A
Start price
Target price
Perf. (%)
€11.72
€21.00
49.97%
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Revenue decline/stagnation expected
AstraZeneca plc
Start price
Target price
Perf. (%)
€95.39
€105.50
-16.31%
Future proof or reliable business model
Small cyclical dependencies
Known brand
Royal Dutch Shell A
Start price
Target price
Perf. (%)
€14.75
€15.00
21.11%
Could be worthwhile Investment >10% per year
British American Tobacco PLC
Start price
Target price
Perf. (%)
€28.13
€53.00
22.47%
Could be worthwhile Investment >10% per year
Very high dividend yield expected
Very capable Management
Very good company culture
